Michael Patrick Miller

Insider Reports History

Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin 4, Ireland
Signature
/s/ Gordon Esplin as attorney-in-fact for Michael Patrick Miller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Patrick Miller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PUMA BIOTECHNOLOGY, INC. Director Common Stock 74K $223K $3.01 Jun 11, 2025 Direct
BioXcel Therapeutics, Inc. Director Stock Option (Right to Buy) 17K Jun 10, 2024 Direct

Insider Reports Filed by Michael Patrick Miller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PBYI PUMA BIOTECHNOLOGY, INC. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
PBYI PUMA BIOTECHNOLOGY, INC. Aug 12, 2024 1 -$81.5K 4 Aug 13, 2024 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 18, 2024 1 $0 4 Jun 21, 2024 Director
BTAI BioXcel Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 11, 2024 Director
PBYI PUMA BIOTECHNOLOGY, INC. Nov 7, 2023 1 -$70.8K 4 Nov 9, 2023 Director
BTAI BioXcel Therapeutics, Inc. Jun 26, 2023 1 $0 4 Jun 28, 2023 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2023 2 -$46.6K 4 Jun 15, 2023 Director
PBYI PUMA BIOTECHNOLOGY, INC. Aug 9, 2022 1 -$88.8K 4 Aug 10, 2022 Director
BTAI BioXcel Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 5, 2022 Director
BTAI BioXcel Therapeutics, Inc. Jul 1, 2022 0 $0 3 Jul 5, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Mar 16, 2022 1 -$71.8K 4 Mar 17, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director